Humoral and Cellular Immune Responses to BNT162b2 COVID-19 Vaccination in Children with Cancer
Amy Body(Monash Health), Eva Segelov(University of Bern), Sriganesh Srihari(QIMR Berghofer Medical Research Institute), Noemi Fuentes Bolanos(Children's Cancer Institute Australia), Jim Buttery(Royal Children's Hospital), Tracey O apos Brien, Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Elizabeth Ahern(Monash Health), William D. Rawlinson(New South Wales Department of Health), Corey Smith(QIMR Berghofer Medical Research Institute), Vivienne Milch(Flinders University), Stuart Turville(UNSW Sydney), Bhavna Padhye(Children's Hospital at Westmead), Antoinette Anazodo(Sydney Children's Hospital), Michelle Haber(Cancer Clinic), C. Raina MacIntyre(UNSW Sydney), Luxi Lal(Monash Health), Peter Downie(Monash Children’s Hospital), Zin Naing(New South Wales Department of Health)
Cited by 0
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
The role of particle size in aerosolised pathogen transmission: A review
|Journal of Infection|2010|698
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
|British Journal of Cancer|2009|404
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272